ArticleMicroorganisms2025
Effects of Rumen-Protected Methionine and Lysine on the Fecal Microbiota of Leizhou Goats.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of the characteristics of microRNA expression profiles and reproductive regulation-mediated signalling pathways in testicular sertoli derived sEVs from Leizhou goats.Veterinary research communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study investigates the effects of rumen-protected methionine and lysine (RPML) on the fecal microbiota of Leizhou goats, focusing on growth performance and fecal microbial community composition. A total of 10 three-month female Leizhou goats (9.90 ± 0.08 kg) were randomly assigned to one of two dietary treatments: a CON group fed a basal diet and an RPML group receiving the basal diet supplemented with 1.5 g/d/head of rumen-protected methionine and 4.5 g/d/head of rumen-protected lysine. Results indicated that RPML significantly enhanced average daily gain (ADG) and final body weight (FBW), as well as significantly decreased the ratio of dry matter intake (DMI) to ADG (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.